Project BioShield News
Most Popular Project BioShield Story
Emerging Drug Developer: Hollis-Eden
When Richard Hollis got up on March 7, he was the CEO of a company that was primarily known for its work advancing Neumune, a therapy for acute radiation syndrome and a prime candidate for... Read more...
Latest Headlines
- August 31, 2007
- August 30, 2007
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
